Abstract:The UK Biobank project is a prospective cohort study with deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69 at recruitment.The open resource is unique in its size and scope.A rich variety of phenotypic and health-related information is available on each participant, including biological measurements, lifestyle indicators, biomarkers in blood and urine, and imaging of the body and brain.Follow-up information is provided by linking health and medical records.Genome-wide genotype data have been collected on all participants, providing many opportunities for the discovery of new genetic associations and the genetic bases of complex traits.Here we describe the centralized analysis of the genetic data, including genotype quality, properties of population structure and relatedness of the genetic data, and efficient phasing and genotype imputation that increases the number of testable variants to around 96 million.Classical allelic variation at 11 human leukocyte antigen genes was imputed, resulting in the recovery of signals with known associations between human leukocyte antigen alleles and many diseases.Understanding the role that genetics has in phenotypic and disease variation, and its potential interactions with other factors, is crucial for a better understanding of human biology.It is hoped that this will lead to more successful drug development 1 , and potentially to more efficient and personalized treatments.As such, a key component of the UK Biobank resource has been the collection of genome-wide genetic data on every participant using a purpose-designed genotyping array 2 .An interim release of genotype data on approximately 150,000 UK Biobank participants in May 2015 3 has already facilitated numerous studies [4][5][6] .In this paper, we summarize the existing and planned content of the phenotype resource and describe the genetic dataset on the full 500,000 participants.To facilitate its wider use, we applied a range of quality control procedures and conducted a set of analyses that reveal properties of the genetic data-such as population structure and relatedness-that can be important for downstream analyses.In addition, we estimated haplotypes and imputed genotypes into the dataset that increases the number of testable variants by more than 100-fold to approximately 96 million variants.We also imputed classical allelic variation at 11 human leukocyte antigen (HLA) genes, and replicated signals of known associations between HLA alleles and many common diseases.We describe tools that allow efficient genomewide association studies (GWAS) of multiple traits and fast phenome-wide association studies, which work together with a new compressed file format that has been used to distribute the dataset.As a further check of the genotyped and imputed datasets, we performed a test-case genome-wide association scan on a well-studied human trait, standing height.

Yield of genetic association signals from genomes, exomes and imputation in the UK Biobank

Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes

Efficient Identification of Trait-Associated Loss-of-function Variants in the UK Biobank Cohort by Exome-Sequencing Based Genotype Imputation

Exome sequencing and analysis of 454,787 UK Biobank participants

Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects

Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Identifying novel genetic and phenotypic associations to genomic features by leveraging off-target reads in exome sequencing data

Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits.

Genetic associations of protein-coding variants in human disease

Faculty Opinions Recommendation of the UK Biobank Resource with Deep Phenotyping and Genomic Data.

Improving GWAS discovery and genomic prediction accuracy in biobank data

Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank

Multi-trait genome-wide analyses of the brain imaging phenotypes in UK Biobank

Using Off-Target Data from Whole-Exome Sequencing to Improve Genotyping Accuracy, Association Analysis and Polygenic Risk Prediction.

Clinical application of whole-exome sequencing across clinical indications

Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank

Analyses of biomarker traits in diverse UK biobank participants identify associations missed by European-centric analysis strategies

Efficient variant set mixed model association tests for continuous and binary traits in large-scale whole genome sequencing studies

Genetic analyses of diverse populations improves discovery for complex traits

Population scale whole genome sequencing provides novel insights into cardiometabolic health